StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2022 - 05 - 09
8
Sector
Electronic technology
1
Health technology
6
Manufacturing
1
Tags
Acquisition
11
Air
3
America
4
Announcement
3
Autonomous
3
Awards
4
Bio-nc
3
Biopharma
3
Bioscience
4
Biotech-bay
10
Biotech-beach
8
Biotechnology
6
Blood
3
Cancer
5
Care
3
Ceo
9
Collaboration
6
Commercial
5
Communications
3
Conference
29
Control
3
Corporation
14
Covid-19
4
Day
3
Disease
8
Drug
5
Earnings
9
Energy
14
Europe
8
Events
7
Expected
7
Food
4
Genetown
5
Group
8
Growth
19
Health
4
International
8
Management
6
Market
46
Media
4
N/a
371
People
4
Pharm-country
6
Pharmaceutical
4
Presentation
5
Program
7
Report
22
Research
15
Results
118
Sales
4
Service
4
Services
7
Solutions
10
System
5
Technology
14
Test
4
Therapeutics
24
Treatment
4
Trial
7
Vaccine
4
Entities
Achilles therapeutics plc - adr
1
Adc therapeutics sa
1
Akari therapeutics plc
1
Axsome therapeutics, inc.
1
Enphase energy, inc.
1
Jazz pharmaceuticals plc
1
Liminal biosciences inc.
1
Myovant sciences ltd.
1
Sanofi
1
Symbols
ACHL
1
ADCT
1
AKTX
1
AXSM
1
ENPH
1
JAZZ
1
LMNL
1
MYOV
1
SNY
1
SNYNF
1
Exchanges
Nasdaq
6
Nyse
2
Crawled Date
2023 - 09 - 11
7
2023 - 05 - 09
10
2023 - 05 - 03
8
2023 - 03 - 15
9
2023 - 02 - 14
7
2023 - 01 - 31
8
2023 - 01 - 17
7
2022 - 11 - 03
7
2022 - 07 - 28
7
2022 - 06 - 23
8
2022 - 05 - 16
7
2022 - 05 - 09
8
2022 - 03 - 16
7
2022 - 02 - 24
10
2022 - 02 - 18
10
2022 - 02 - 16
9
2022 - 02 - 14
7
2022 - 02 - 10
8
2022 - 02 - 07
8
2022 - 01 - 26
7
2021 - 12 - 20
7
2021 - 12 - 15
7
2021 - 12 - 14
7
2021 - 12 - 13
10
2021 - 11 - 30
9
2021 - 11 - 29
7
2021 - 11 - 23
7
2021 - 11 - 17
7
2021 - 11 - 16
8
2021 - 11 - 12
7
2021 - 11 - 10
8
2021 - 10 - 28
7
2021 - 10 - 25
8
2021 - 10 - 20
7
2021 - 10 - 14
8
2021 - 10 - 13
9
2021 - 10 - 04
7
2021 - 09 - 20
10
2021 - 09 - 13
12
2021 - 09 - 01
10
2021 - 08 - 30
8
2021 - 08 - 24
6
2021 - 08 - 23
8
2021 - 07 - 21
6
2021 - 07 - 15
6
2021 - 06 - 28
7
2021 - 06 - 25
10
2021 - 06 - 24
8
2021 - 06 - 23
7
2021 - 06 - 18
7
2021 - 06 - 17
6
2021 - 06 - 11
14
2021 - 06 - 08
7
2021 - 06 - 07
9
2021 - 05 - 25
7
2021 - 05 - 24
6
2021 - 05 - 21
8
2021 - 05 - 12
14
2021 - 04 - 27
6
2021 - 04 - 20
7
Crawled Time
11:00
1
12:00
2
13:00
1
14:00
3
22:00
1
Source
www.biospace.com
7
www.globenewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Europe
crawled date :
2022 - 05 - 09
save search
Enphase Energy Announces IQ™ Battery Compatibility with Third-Party Inverters in Europe
Published:
2022-05-09
(Crawled : 22:00)
- globenewswire.com
ENPH
S
|
$112.075
1.45%
1.43%
3.6M
|
Electronic Technology
|
-33.41%
|
O:
-3.31%
H:
2.08%
C:
-6.17%
battery
europe
energy
MoonLake Immunotherapeutics announces the publication of new long-term disease control data from a Phase 2b Psoriasis trial of the Nanobody® sonelokimab
Published:
2022-05-09
(Crawled : 14:00)
- biospace.com/
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-10.34%
|
O:
-0.84%
H:
0.0%
C:
0.0%
nanobody
disease
control
trial
psoriasis
publication
phase 2b
Achilles Therapeutics Doses First Patient with Higher-dose cNeT in Phase I/IIa CHIRON Trial in Advanced NSCLC and Initiates Enrollment in Cohort B of the THETIS Trial (cNeT + PD-1 checkpoint inhibitor) in Metastatic Malignant Melanoma
Published:
2022-05-09
(Crawled : 14:00)
- biospace.com/
ACHL
|
$0.8
-0.27%
-0.28%
180K
|
Manufacturing
|
-62.86%
|
O:
0.46%
H:
1.84%
C:
-9.68%
trial
therapeutics
enroll
Akari Presents Results from Two Preclinical Development Programs of Long-Acting PAS-Nomacopan in Geographic Atrophy (GA) Dry Age-Related Macular Degeneration and Nomacopan in Experimental Immune-Mediated Conjunctival Disease (EIC)
Published:
2022-05-09
(Crawled : 14:00)
- biospace.com/
AKTX
|
$1.1555
-1.69%
7.9K
|
Health Technology
|
2.26%
|
O:
-0.88%
H:
2.68%
C:
0.89%
disease
preclinical
macular
results
pre-clinical
Liminal Biosciences to Present at Upcoming Investor Conferences
Published:
2022-05-09
(Crawled : 13:00)
- biospace.com/
LMNL
|
$8.5
0.12%
0.12%
0
|
Health Technology
|
1096.68%
|
O:
-5.67%
H:
6.01%
C:
-2.54%
bioscience
ADC Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates
Published:
2022-05-09
(Crawled : 12:00)
- biospace.com/
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-60.73%
|
O:
-3.94%
H:
1.1%
C:
-28.08%
therapeutics
results
Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics
Published:
2022-05-09
(Crawled : 12:00)
- biospace.com/
JAZZ
|
News
|
$107.15
-1.61%
-1.63%
590K
|
Health Technology
|
-29.09%
|
O:
-1.4%
H:
0.61%
C:
-4.73%
AXSM
|
$69.69
1.28%
1.26%
400K
|
Health Technology
|
94.32%
|
O:
-17.99%
H:
1.48%
C:
-7.64%
sunosi
therapeutics
solriamfetol
Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe
Published:
2022-05-09
(Crawled : 11:00)
- biospace.com/
MYOV
|
$26.98
-0.04%
0.0%
0
|
Health Technology
|
184.45%
|
O:
-10.28%
H:
0.0%
C:
0.0%
orgovyx
europe
license
cancer
prostate cancer
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.